Latest Brain tumor Stories
VANCOUVER, British Columbia and MENLO PARK, Calif., May 29, 2015 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQX: DMPI)
The National Non-profit Organization Continues to Advocate for Brain Cancer and Tumor Research to Ultimately Find a Cure NEW YORK, May 28, 2015 /PRNewswire-USNewswire/ --
VANCOUVER, British Columbia and MENLO PARK, Calif., May 27, 2015 /PRNewswire/ -- DelMar Pharmaceuticals,
NEW YORK, May 27, 2015 /PRNewswire/ -- US-Australian drug discovery and development company, Novogen Limited (ASX: NRT; NASDAQ: NVGN), announced today that it will present at the Brain Tumor
Distinguished International Key Opinion-Leaders Board of Neuro-Oncologists Provide Invaluable Guidance to the Company's Metronomic Biofeedback Pump Team LOS ANGELES, May 26, 2015 /PRNewswire/
Aldoxorubicin Has Now Shown Two Complete Responses, In Addition to Tumor Shrinkage, Prolonged Stable Disease, and Favorable Tolerability in Patients LOS ANGELES, May 21, 2015 /PRNewswire/
--Collaboration Combines Companies' Expertise in Oncolytic Virus Therapy and Targeted Drug Delivery-- LOWELL, Mass.
Comprehensive information and support for patients and caregivers at http://www.abta.org Chicago, Ill.
- Lead product candidate, VAL-083 for the treatment of glioblastoma multiforme (GBM), positioned to enter registration-directed Phase II/III clinical trials in 2H 2015 - VANCOUVER, British
Collaboration announced during Brain Cancer Awareness Month will spotlight life-saving activities and research projects. Plainsboro, NJ (PRWEB) May 15, 2015
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.